Word

LUNGCLEAR

Status

Pending

Status Code

681

Status Date

Thursday, May 2, 2024

Serial Number

79366536

Mark Type

4

Filing Date

Wednesday, January 18, 2023

Published for Opposition

Tuesday, June 4, 2024

Trademark Owner History

MIRXES PTE. LTD.

Classifications

5 Diagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosis, namely, for detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical and veterinary purposes; Diagnostic reagents for medical and veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical and veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use in the medical field; Test reagents for medical diagnosis, namely, disease testing; diagnostic biomarker reagents for medical purposes; Chemical preparations for diagnostic medical purposes, namely, for detecting and diagnosing cancer; Chemical preparations for use in medical diagnostics, namely, nucleic acid analysis; Chemical preparations for detecting genetic and epigenetic predispositions for medical purposes; Medical diagnostic reagents for analysis of body fluids; Synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use, namely, for detecting and diagnosing cancer; nucleic acid amplification reagents for medical use

44 Medical diagnostic services, namely, testing and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical services, namely, nucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical services, namely, health risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical services, namely, nucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer

10 Medical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNA, DNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNA, DNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedures, namely, testing DNA, RNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use

LUNG CLEAR

Trademark Events

Mar 31, 2023

Sn Assigned For Sect 66a Appl From Ib

Apr 7, 2023

Application Filing Receipt Mailed

Oct 17, 2023

Assigned To Examiner

Oct 19, 2023

Non-Final Action Written

Oct 20, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Oct 27, 2023

Refusal Processed By Mpu

Oct 27, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Nov 22, 2023

Refusal Processed By Ib

Apr 26, 2024

Teas/Email Correspondence Entered

Apr 26, 2024

Correspondence Received In Law Office

Apr 26, 2024

Teas Response To Office Action Received

Apr 30, 2024

Approved For Pub - Principal Register

Apr 3, 2023

New Application Office Supplied Data Entered